John Rotrosen
Impact in
- Psychiatry and Mental health top 0.2%
- Schizophrenia research and treatment
- Attention Deficit Hyperactivity Disorder
- Biological Psychiatry top 0.5%
Papers in
-
- Schizophrenia research and treatment 53
-
- Neurotransmitter Receptor Influence on Behavior 40
- Neuroscience and Neuropharmacology Research 20
- Co-authors
- Lenard A. AdlerBurt AngristSamuel GershonAdam WolkinBurton AngristEric D. PeselowMichael SanfilipoMichael P. Milham
- Journals
- Psychopharmacology (20 papers)Biological Psychiatry (18 papers)Journal of Substance Abuse Treatment (17 papers)American Journal of Psychiatry (13 papers)Life Sciences (13 papers)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
John Rotrosen
275 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Psychiatry and Mental health 3.7k
- Biological Psychiatry 469
- Cognitive Neuroscience 3.0k
- Cellular and Molecular Neuroscience 2.5k
- Behavioral Neuroscience 281
Countries citing papers authored by John Rotrosen
This map shows the geographic impact of John Rotrosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rotrosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rotrosen more than expected).
Fields of papers citing papers by John Rotrosen
This network shows the impact of papers produced by John Rotrosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rotrosen. The network helps show where John Rotrosen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Rotrosen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 7 | |
| 5 | 2018 | 109 | |
| 6 | 2016 | 225 | |
| 7 | 2013 | 17 | |
| 8 | 2009 | 9 | |
| 9 | 2008 | 169 | |
| 10 | 2007 | 17 | |
| 11 | 2007 | 102 | |
| 12 | 2006 | 16 | |
| 13 | 2001 | 44 | |
| 14 | 2000 | 23 | |
| 15 | 1991 | 3 | |
| 16 | 1990 | 30 | |
| 17 | 1989 | 14 | |
| 18 | Effect of lithium on the membrane-bound magnesium-dependent ATPase of mouse neuroblastoma cells. | 1978 | 1 |
| 19 | Neuroendocrine studies with dopamine agonists in schizophrenia. | 1978 | 22 |
| 20 | A morphanthridine derivative in schizophrenic patients -- lack of extrapyramidal symptoms. | 1976 | 2 |
About John Rotrosen
John Rotrosen is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience, Biological Psychiatry, Epidemiology and Public Health, Environmental and Occupational Health, having authored 282 papers that have together received 10.4k indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (79 papers), Opioid Use Disorder Treatment (71 papers), Schizophrenia research and treatment (53 papers), Neurotransmitter Receptor Influence on Behavior (40 papers), Prenatal Substance Exposure Effects (22 papers), Neuroscience and Neuropharmacology Research (20 papers), Receptor Mechanisms and Signaling (18 papers) and HIV, Drug Use, Sexual Risk (16 papers). The work is most often cited by research in Psychiatry and Mental health (3.7k citations), Biological Psychiatry (469 citations), Cognitive Neuroscience (3.0k citations), Cellular and Molecular Neuroscience (2.5k citations) and Behavioral Neuroscience (281 citations). John Rotrosen has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Lenard A. Adler, Burt Angrist, Samuel Gershon, Adam Wolkin, Burton Angrist, Eric D. Peselow, Michael Sanfilipo, Michael P. Milham, Clare Kelly and F. Xavier Castellanos. Their work appears in journals such as Psychopharmacology, Biological Psychiatry, Journal of Substance Abuse Treatment, American Journal of Psychiatry and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.